VoICE Immunization Evidence

Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity

Authored by: Stack, M. L., Ozawa, S., Bishai, D. M., et al.

Appears in:

Key Idea

In a modeled analysis of the economic impact of vaccine use in the world’s 72 poorest countries, for countries included in the analyses from the African region, scaling up coverage of the Rotavirus (RVV) vaccine to 90% was projected to result in more than $900 million in treatment costs averted.

Published In

Stack, M. L., Ozawa, S., Bishai, D. M., et al. 2011. Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity. Health Affairs. 30(6).